The transmembrane replacement H7N9-VLP vaccine displays high levels of protection in mice.

Qin, Jianru; Hu, Bing; Song, Qiqi; Wang, Ruijuan; Zhang, Xiangfei; Yu, Yaqi; Wang, Jian-Hua

Qin, Jianru; Hu, Bing; Song, Qiqi; Wang, Ruijuan; Zhang, Xiangfei; Yu, Yaqi; Wang, Jian-Hua.

Afiliação

Qin J; College of Life Sciences, Henan Normal University, Xinxiang, China.
Hu B; College of Life Sciences, Henan Normal University, Xinxiang, China.
Song Q; College of Life Sciences, Henan Normal University, Xinxiang, China.
Wang R; College of Life Sciences, Henan Normal University, Xinxiang, China.
Zhang X; College of Life Sciences, Henan Normal University, Xinxiang, China.
Yu Y; College of Life Sciences, Henan Normal University, Xinxiang, China.
Wang JH; Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.

Front Microbiol ; 13: 1003714, 2022.

Article em En | MEDLINE | ID: mdl-36274725

Palavras-chave

BALB/c; H7N9 influenza virus; passive immunity; vaccine; virus-like particles

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Microbiol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google